McKesson Corporation MCK NYSE

McKesson Corporation (MCK) reported total assets of $75.14B and total liabilities of $76.83B for fiscal year 2025, resulting in total equity of $-1.69B.

The company held $5.69B in cash and short-term investments. Total debt stood at $7.39B, with net debt of $1.7B. The Debt-to-Equity (D/E) ratio was -4.36 (conservative).

Current ratio is 0.9, which may signal tight short-term liquidity. Interest coverage is 16.7x (strong).

Criteria supported by this page:

• HEALTH (50/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (55/100) — Total assets $75.14B and equity $-1.69B support the company's competitive scale
• VALUE (51/100) — Debt-to-Equity -4.36 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 65/100 with 3/7 criteria passed.

SYK

Stryker Corporation

$345.88

-0.39%

GSK

GSK plc

$59.18

+0.41%

BMY

Bristol-Myers Squibb Company

$58.08

+0.03%

SNY

Sanofi

$47.64

+1.45%

MDT

Medtronic plc

$88.12

+0.14%

VRTX

Vertex Pharmaceuticals Incorporated

$444.28

+0.96%

HCA

HCA Healthcare, Inc.

$498.66

+0.25%

CVS

CVS Health Corporation

$77.62

-0.60%